Nplate and Valacyclovir drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Nplate (romiplostim) and Valacyclovir (valacyclovir hydrochloride). Common drug interactions include platelet count decreased among females and thrombocytopenia among males.
The phase IV clinical study analyzes what interactions people have when they take Nplate and Valacyclovir. It is created by eHealthMe based on reports of 70 people who take the same drugs from the FDA, and is updated regularly.
What is Nplate?
Nplate has active ingredients of romiplostim. It is often used in idiopathic thrombocytopenic purpura (itp). eHealthMe is studying from 17,850 Nplate users. Check the latest studies of Nplate.
What is Valacyclovir?
Valacyclovir has active ingredients of valacyclovir hydrochloride. It is often used in genital herpes. eHealthMe is studying from 42,107 Valacyclovir users. Check the latest studies of Valacyclovir.
70 people who take Nplate and Valacyclovir together, and have interactions are studied.

What are the common drug interactions of Nplate and Valacyclovir, by gender? *:
female:
- Platelet count decreased
- Skin disorder (skin disease)
- Small cell lung cancer stage unspecified (lung cancer in unknown stage)
- Sputum discoloured
- Therapeutic response decreased (less preventive response)
- Urticaria (rash of round, red welts on the skin that itch intensely)
- White blood cell count decreased
- White blood cell count increased
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Emphysematous cystitis (inflammation of the urinary bladder)
male:
- Thrombocytopenia (decrease of platelets in blood)
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
- Leukocytosis (increased white blood cells)
- Petechiae (a small red or purple spot caused by bleeding into the skin)
- Pseudohyperkalaemia (marked increase of in vitro serum potassium levels)
- Purpura (purplish discoloration of the skin)
- Septic shock (shock due to blood infection)
- Urinary hesitation (difficulty in beginning the flow of urine)
- Urinary tract obstruction
- Volvulus (obstruction caused by twisting of the stomach or intestine)
What are the common drug interactions of Nplate and Valacyclovir, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Pulmonary hypertension (increase in blood pressure in the lung artery)
- Right ventricular failure (right half of the heart fails to work)
20-29:
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Platelet count decreased
30-39:
n/a
40-49:
n/a
50-59:
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Pyrexia (fever)
- Erythema multiforme (a type of hypersensitivity reaction)
- Abdominal pain
- Acute respiratory distress syndrome
- Death
- Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
60+:
- Neutropenia (an abnormally low number of neutrophils)
- Thrombocytopenia (decrease of platelets in blood)
- Enterocolitis infectious
- Hypokalaemia (low potassium)
- Influenza like illness
- Leukocytosis (increased white blood cells)
- Petechiae (a small red or purple spot caused by bleeding into the skin)
- Pseudohyperkalaemia (marked increase of in vitro serum potassium levels)
- Purpura (purplish discoloration of the skin)
- Urinary hesitation (difficulty in beginning the flow of urine)
What are the existing conditions these people have? *
- Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 20 people, 28.57%
- Pain: 19 people, 27.14%
- Nausea (feeling of having an urge to vomit): 19 people, 27.14%
- Febrile Bone Marrow Aplasia (bone marrow greatly decreases or stops production of blood cells): 18 people, 25.71%
- Venoocclusive Disease (small veins in the liver are obstructed): 17 people, 24.29%
- High Blood Pressure: 17 people, 24.29%
- Fungal Infection: 17 people, 24.29%
- Blood Disorder: 17 people, 24.29%
- Abdominal Pain Upper: 17 people, 24.29%
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 9 people, 12.86%
* Approximation only. Some reports may have incomplete information.
Do you take Nplate and Valacyclovir?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Nplate (17,850 reports)
- Valacyclovir (42,107 reports)
Browse all drug interactions of Nplate and Valacyclovir:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Nplate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Valacyclovir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Nplate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Valacyclovir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on romiplostim and valacyclovir hydrochloride (the active ingredients of Nplate and Valacyclovir, respectively), and Nplate and Valacyclovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Vicodin cause Adrenal Disorder? - now
- Drug interactions of Noxafil and Procardia - a second ago
- Drug interactions of Prednisolone and Cerubidine - a second ago
- Drug interactions of Percocet and Microzide - 9 seconds ago
- Drug interactions of Caduet and Enbrel - 9 seconds ago
- Drug interactions of Restasis and Azathioprine - 10 seconds ago
- Drug interactions of Camptosar and Zide - 15 seconds ago
- Drug interactions of Colace and Nuvigil - 16 seconds ago
- Drug interactions of Arthrotec and Flomax - 16 seconds ago
- Drug interactions of Dipyridamole and Pentoxifylline - 17 seconds ago